黄露婷,李国胜
HUANG Luting,LI Guosheng

• 1:贵州医科大学附属医院全科医学科
• 2:贵州医科大学临床医学院
• 3:贵州医科大学附属医院结直肠肛门外科

摘要(Abstract)：

目的 分析结直肠癌并胆囊切除术后患者的实验室指标及病理特征。方法 将收治的结直肠癌合并胆囊切除术后患者57例作为病例组、同期收治的单纯结直肠癌患者101例为对照组，收集两组患者的一般资料[年龄、性别、体质量指数(BMI)、高血压、糖尿病、胆囊相关手术史]、实验室检查资料[血胆汁酸、甲胎蛋白(AFP)、癌胚抗原(CEA)、糖类抗原(CA)系列(CA125、CA15-3、CA72-4、CA242、CA19-9)]及病理学资料[肿瘤的部位、分期、浸润深度、远处转移、淋巴结转移、肿瘤蛋白53(P53)、是否为错配修复蛋白缺失(dMMR)结直肠癌],比较两组患者实验室指标及病理学资料的差异，采用多因素logistic分析结肠癌合并胆囊切除术后患者相关危险因素。结果 实验组患者平均年龄、女性比例、糖类抗原19-9(CA19-9)阳性率、糖类抗原242(CA242)阳性率、人类表皮生长因子受体2(HER2)阳性率、淋巴结转移率高于对照组，差异有统计学意义(P<0.05),多因素logistic分析提示性别、年龄是胆囊切除术后患者并结直肠癌的独立危险因素(P<0.05)。结论 结直肠癌合并胆囊切除术后患者易发生淋巴结转移，且女性患病风险高于男性，提示预后差，复发风险高。
Objective To analyze the laboratory examination data and pathological characteristics of patients with colorectal cancer complicated with cholecystectomy. Methods A total of 57 patients with colorectal cancer complicated with cholecystectomy were selected as an experimental group, and 101 patients only with colorectal cancer admitted at the same period were selected as a control group. The data of two groups of the patients were collected, including general data [age, gender, body mass index(BMI), hypertension, diabetes and gallbladder-related surgery history], laboratory examination data [blood bile acid, alpha-fetoprotein(AFP), carcinoembryonic antigen(CEA), carbohydrate antigen(CA) series(including CA125, CA15-3, CA72-4, CA242, and CA19-9)] and pathology data [tumor site, stage, infiltration depth, distant metastasis, lymph node metastasis, tumor protein 53(P53) and whether mismatch repair protein deficiency(dMMR) was in colorectal cancer]. The differences in laboratory indicators and pathological data were compared between two groups of the patients. Multivariate logistic analysis was performed to identify relevant risk factors for the patients with colorectal cancer complicated with cholecystectomy. Results The average age, female proportion, CA19-9 positive rate, CA242 positive rate, HER2 positive rate and the rate of lymph node metastasis of experimental group were higher than those of control group(P<0.05). Multivariate logistic analysis suggested that gender and age were independent risk factors for the patients with colorectal cancer complicated with cholecystectomy(P<0.05). Conclusion The patients colorectal cancer complicated with cholecystectomy are more prone to have lymph node metastasis, among them, women have a higher risk of illness than men, indicating poor prognosis and high risk of recurrence.

关键词(KeyWords)： 结直肠肿瘤;胆囊切除术;临床特点;三级预防;危险因素
colorectal cancer;cholecystectomy;clinical characteristics;tertiary prevention;risk faltors

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 黄露婷,李国胜
HUANG Luting,LI Guosheng

DOI: 10.19367/j.cnki.2096-8388.2024.07.015

参考文献(References)：

• [1] 刘宗超，李哲轩，张婧莹，等.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志，2021,7(2):1-14.
• [2] XI Y,XU P.Global colorectal cancer burden in 2020 and projections to 2040.[J].Transl-ational Oncology,2021,14(10):101174.
• [3] 高明，曹明溶，劳学军.中国人群胆囊结石与大肠癌发生相关性的Meta分析[J].南方医科大学学报，2010,30(5):1174-1176.
• [4] 张伟鹏，孙逸飞，田忠.胆囊切除与结直肠癌的关系研究进展[J].肝胆胰外科杂志，2021,33(1):53-55,60.
• [5] 蒋栋铭，张丽娟，刘文斌，等.2004—2018年中国癌症死亡趋势：一项全国性纵向研究[J].癌症，2022,41(9):443-455.
• [6] PECCI F,CANTINI L,BITTONI A,et al.Beyond microsatellite instability:evolving stra-tegies integrating immunotherapy for microsatellite stable colorectal cancer[J].Current Treatment Options in Oncology,2021,22(8):69.
• [7] ZHANG Y,LIU H,GONG Z,et al.Cholecystectomy can increase the risk of colorectal cancer:a meta-analysis of 10 cohort studies.[J].PloS One,2017,12(8):e0181852.
• [8] KIM S B,KIM K O,KIM T N.Prevalence and risk factors of gastric and colorectal cancer after cholecystectomy[J].Journal of Korean Medical Science,2020,35(42):e354.
• [9] KUHLS S,OSSWALD A,OCVIRK S.Bile acids,bile pigments and colorectal cancer risk[J].Current Opinion in Gastroenterology,2022,38(2):173-178.
• [10]YAO Y,XU B,LUO L,et al.Cholecystectomy promotes colon carcinogenesis by activati-ng the wnt signaling pathway by increasing the deoxycholic acid level[J].Cell Communication and Signaling,2022,20(1):71.
• [11]BASBUG M,ARIKANOGLU Z,BULBULLER N,et al.Prognostic value of preoperative CEA and CA 19-9 levels in patients with colorectal cancer[J].Hepatogastroenterology,2011,58(106):400-405.
• [12]RAO H,WU H,HUANG Q,et al.Clinical value of serum CEA,CA24-2 and CA19-9 in patients with colorectal cancer[J].Clinical Laboratory,2021,67(4):1079-1089.
• [13]OKAMURA R,HASEGAWA S,HIDA K,et al.The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.[J].International Journal of Clinical Oncology,2017,22(1):96-101.
• [14]LI Z,ZHU H,PANG X,et al.Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA:a multicenter retrosp-ective cohort study[J].BMC Cancer,2022,22(1):962.
• [16]BERTOTTI A,MIGLIARDI G,GALIMI F,et al.A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer[J].Cancer Discovery,2011,1(6):508-523.
• [17]NAOKI T,KIMIO Y.Human epithelial growth factor receptor type 2 as an emerging oncotarget for colorectal cancer treatment after failure of anti-epidermal growth factor re-ceptor therapy[J].Clinical Colorectal Cancer,2017,16(4):247-251.
• [18]GANG L,JUNHUA Z,BIN X,et al.Simvastatin inhibits tumor angiogenesis in HER2-overexpressing human colorectal cancer[J].Biomedicine & Amp;Pharmacotherapy,2017,85:418-424.
• [19]LU Y,GAO J,BAORONG S,et al.Expression of EGFR,Her2 predict lymph node met-astasis(LNM)-associated metastasis in colorectal cancer[J].Cancer Biomarkers,2012,11(5):219-226.
• [20]孙旭凌，黄桂林，李豫江，等.结直肠癌HER2及Ki-67表达的关系及预后因素分析[J].重庆医学，2018,47(12):1610-1615.

文章评论(Comment)：